Security key
426897104
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)
CUSIP: 426897104
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 29,123,952
- Total 13F shares
- 207,666
- Share change
- +47,257
- Total reported value
- $367,000
- Price per share
- $1.76
- Number of holders
- 5
- Value change
- -$227,082
- Number of buys
- 4
- Number of sells
- 7
Report period
Q1 2020
Institutions
5
Top holders
5
HEPA full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897104
Recent filing periods:
Top shareholders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
0.21%
|
60,636
|
$325,000 | — | 31 Dec 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.15%
|
43,039
|
$231,000 | — | 31 Dec 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.06%
|
17,233
|
$92,000 | — | 31 Dec 2019 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
14,741
|
$79,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
13,927
|
$74,000 | — | 31 Dec 2019 | |
| Prospera Financial Services Inc |
13F
|
Company |
0.05%
|
13,113
|
$70,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
7,034
|
$37,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,519
|
$19,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,322
|
$18,000 | — | 31 Dec 2019 | |
| American Portfolios Advisors |
13F
|
Company |
0.01%
|
2,000
|
$10,720 | — | 31 Dec 2019 | |
| Sowell Financial Services LLC |
13F
|
Company |
0%
|
105
|
$1,000 | — | 31 Dec 2019 |
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q1 2020
As of 31 Mar 2020,
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
207,666 shares.
The largest 5 holders included
SABBY MANAGEMENT, LLC, BlackRock Inc., Prospera Financial Services Inc, DIMENSIONAL FUND ADVISORS LP, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
This page lists
5
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
11
Q1 2020 holders
5
Holder diff
-6
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.